Terapia nutricional de paciente com ataxia-telangiectasia: relato de caso
Nutrition therapy of a patient with ataxia-telangiectasia: case report
Talita Lemos Neves Barreto; Juliana Fernandez Santana Meneses; Roseli Oselka Saccardo Sarni
Resumo
Neste artigo relatamos a terapia nutricional de um paciente com ataxia-telangiectasia (A-T) utilizando a gastrostomia (GTM) como via alternativa para alimentação. Paciente do sexo masculino, 13 anos de idade, com diagnóstico clínico de A-T aos 6 anos. Aos 8 anos e 7 meses o paciente foi identificado com risco nutricional (ZIMC/I: -1,67). Após 1 ano, evoluiu de forma desfavorável (ZIMC/I: -2,51) apesar da intervenção nutricional, sendo indicada a GTM aos 9 anos e 11 meses. No entanto, em decorrência da dificuldade de aceitação dos pais, o procedimento foi realizado somente quando o adolescente completou 11 anos e 7 meses. Inicialmente foi prescrita para oferta pela GTM dieta enteral normocalórica e normoproteica, correspondendo a 45,8% da necessidade energética diária. Após um mês, com estabilidade metabólica, houve a transição para uma dieta enteral hipercalórica e hiperproteica, fornecendo 91,6% da necessidade energética diária. Após 6 meses com a GTM, verificou-se ganho de peso total de 3,3 Kg (ZIMC/I -2,97), após 1 ano de 4,7 Kg (ZIMC/I -2,59), e após 1 ano e 9 meses de 6,7 Kg (ZIMC/I -2,63). Apesar da desnutrição nos pacientes com A-T ter origem multifatorial, o uso da GTM como via alternativa para alimentação por esse paciente resultou em uma evolução favorável dos seus indicadores antropométricos, sendo relatadas poucas intercorrências com a sua utilização. Portanto, sugere-se que pacientes com A-T devam ser monitorados periodicamente por equipe multiprofissional visando à identificação precoce de potenciais agravos.
Palavras-chave
Abstract
In this article we report the nutritional therapy of a patient with ataxia-telangiectasia (A-T) using percutaneous endoscopic gastrostomy (PEG) as an alternative way of feeding. The patient was a 13-year-old male diagnosed with A-T at the age of 6 years. At 8 years and 7 months, the patient was at nutritional risk (body mass index z-score [BMIZ]: -1.67). After 1 year, he had an unfavorable evolution (BMIZ: -2.51), despite nutritional intervention; then, a PEG was indicated when he was 9 years and 11 months. However, due to the difficulty of parental acceptance, the procedure was performed when the adolescent was 11 years and 7 months. At first, a standard energy and protein enteral formula was prescribed, reaching 45.8% of his daily energy requirement. After 1 month, with metabolic stability, there was a transition to a high-energy and protein enteral formula providing 91.6% of his daily energy requirement. After 6 months of PEG placement, the patient had a total body weight gain of 3.3 kg (BMIZ: -2.97); subsequently, body weight increased by 4.7 kg (BMIZ: -2.59) after 1 year, and by 6.7 kg (BMIZ: -2.63) after 1 year and 9 months. Despite the multifactorial origin of malnutrition in A-T patients, PEG placement as an alternative way of feeding for this patient resulted in favorable evolution of his anthropometric indicators, and only a few complications were reported with its use. Therefore, it is suggested that patients with A-T should be monitored periodically by a multidisciplinary team for early identification of potential damages.
Keywords
References
1. Milne RL. Variants in the ATM gene and breast cancer susceptibility. Genome Med. 2009;1(1):12.
2. Swift M. Genetics and epidemiology of ataxia telangiectasia. Kroc Found Ser. 1985;19:133-46.
3. Lavin MF, Lederman HM. Chromosomal breakage syndromes associated with immunodeficiency. In: Stiehm ER, Ochs HD, Winkelstein JA. Immunologic disorders in infants & children. 5ª ed. Philadelphia: Elsevier/Saunders; 2004. p. 580-7.
4. Stray-Pedersen A, Jónsson T, Heiberg A, Lindman CR, Widing E, Aberge IS, et al. The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents. Clin Exp Immunol. 2004 Jul;137(1):179-86.
5. Lavin MF, Lederman HM. Chromosomal breakage syndromes associated with immunodeficiency. In: Stiehm ER, Ochs HD, Winkelstein JA, eds. Immunologic disorders in infants & children. 5ª ed. Philadelphia: Elsevier/Saunders; 2004. p. 580 7.
6. Gatti RA, Becker-Catania S, Chun HH, Sun X, Mitui M, Lai CH, et al. The pathogenesis of ataxia-telangectasia. Learning from a Rosetta Stone. Clin Rev Allergy Immunol. 2001;20(1):87-108.
7. da Silva R, dos Santos-Valente EC, Burim Scomparini F, Saccardo Sarni RO, Costa-Carvalho BT. The relationship between nutritional status, vitamin A and zinc levels and oxidative stress in patients with ataxia telangiectasia. Allergol Immunopathol (Madr). 2014;42(4):329-35. Referências
8. Weiss B, Krauthammer A, Soudack M, Lahad A, Sarouk I, Somech R, et al. Liver Disease in pediatric patients with Ataxia Telangiectasia: A Novel Report. J Pediatr Gastroenterol Nutr. 2016;62:550-5.
9. Paulino TL, Rafael MN, Hix S, Shigueoka DC, Ajzen SA, Kochi C, et al. Is age a risk factor for liver disease and metabolic alterations in ataxia Telangiectasia patients? Orphanet J Rare Dis. 2017;12(1):136.
10. Ambrose M, Gatti RA. Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood. 2013 May;121(20):4036‑45.
11. Verhagen MM, Abdo WF, Willemsen MA, Hogervorst FB, Smeets DF, Hiel JA, et al. Clinical spectrum of ataxia-telangiectasia in adulthood. Neurology. 2009;73:430‑7.
12. Lederman HM, Crawford TO. Visão geral da ataxia telangiectasia. In: St. Jude Children’s Research Hospital – Memphis, Universidade Federal de São Paulo - UNIFESP, Brazilian Group for Immunodeficiencies – BRAGID, eds. Ataxia Telangiectasia: livro para famílias e portadores. São Paulo: Editora Brasileira; 2006. p. 9-10.
13. Ross LJ, Capra S, Baguley B, Sinclair K, Munro K, Lewindon P, et al. Nutritional status of patients with ataxia-telangiectasia: A case for early and ongoing nutrition support and intervention. J Paediatr Child Health. 2015 Aug;51(8):802-7.
14. Ramelli GP, Aloysius A, King C, Davis T, Muntoni F. Gastrostomy placement in paediatric patients with neuromuscular disorders: indications and outcome. Dev Med Child Neurol. 2007;49:367‑71.
15. Institute of Medicine. Dietary Reference Intakes for energy, carbohydrate, fiber, fat, protein, and amino acids (macronutrients). Washington: National Academy Press; 2002.
16. Krauthammer A, Lahad A, Sarouk Y, Somech R, Nissenkorn A, Modan-Moses D, et al. Long-term nutritional and gastrointestinal aspects in patients with ataxia telangiectasia. Nutrition. 2018;46:48‑52.
17. Stewart E, Prayle AP, Tooke A, Pasalodos S, Suri M, Bush A, et al. Growth and nutrition in children with ataxia telangiectasia. Archives of Disease in Childhood. 2016;101:1137-41.
18. Pommerening H, van Dullemen S, Kieslich M, Schubert R, Zielen S, Voss S. Body composition, muscle strength and hormonal status in patients with ataxia telangiectasia: a cohort study. Orphanet J Rare Dis. 2015;10:155.
19. Lefton-Greif MA, Crawford TO, McGrath-Morrow S, Carson KA, Lederman HM. Safety and caregiver satisfaction with gastrostomy in patients with Ataxia Telangiectasia. Orphanet J Rare Dis. 2011;6:23.
20. Sullivan PB, Juszczak E, Bachlet AM, Thomas AG, Lambert B, Vernon-Roberts A, et al. Impact of gastrostomy tube feeding on the quality of life of carers of children with cerebral palsy. Dev Med Child Neurol. 2004;46(12):796‑800.
21. Rouse L, Herrington P, Assey J, Baker R, Golden S. Feeding problems, gastrostomy and families: a qualitative pilot study. Br J Learn Disabil. 2002;30(3),122‑28.
22. Smith L, Daughtrey H. Weaving the seamless web of care: an analysis of parents' perceptions of their needs following discharge of their child from hospital. J Adv Nurs. 2000;31(4):812‑20.
23. Romano C, van Wynckel M, Hulst J, Broekaert I, Bronsky J, Dall’Oglio L, et al. European Society for Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for the evaluation and treatment of gastrointestinal and nutritional complications in children with neurological impairment. J Pediatr Gastroenterol Nutr. 2017;65(2):242‑64.
Submitted date:
04/23/2020
Accepted date:
05/04/2020
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email